William Slayton, MD - Research

Research at a glance

Top areas of exploration

Hematopoietic Stem Cells , 12 publications
Bone Marrow Transplantation , 10 publications
Bone Marrow Cells , 9 publications
Hematopoietic Stem Cell Transplantation , 8 publications

Research activity

86 publications

2,301 citations

Why is this important?

Active clinical trials

A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in P

This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: 2 Years - 25 Years
Sexes: All

A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment o

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: N/A - 22 Years
Sexes: All

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma (RADICAL)

The addition of targeted immunotherapy will be safe and well tolerated and facilitate the reduction of anthracycline exposure while preserving lymphoma disease control in children, adolescents and young adults (CAYA) with mature B-cell non-Hodgkin鈥�

Investigator: William Slayton
Status: Accepting Candidates
Ages: 3 Years - 39 Years
Sexes: All

My publications

86 publications

2015

Near Fatal Presentation of Neuro-Degenerative Langerhans Cell Histiocytosis

Pediatric Blood & Cancer

2015

Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma.

Leukemia & lymphoma

鈥�

2015

Two novel RUNX1 mutations in a patient with congenital thrombocytopenia that evolved into a high grade myelodysplastic syndrome.

Leukemia research reports

鈥�

2014

Bartonella henselae infection inducing hemophagocytic lymphohistiocytosis in a kidney transplant recipient.

Pediatric transplantation

2014

Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia.

Frontiers in oncology

鈥�

网红黑料